Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.240
-0.038 (-1.16%)
At close: May 12, 2025, 4:00 PM
3.150
-0.090 (-2.78%)
After-hours: May 12, 2025, 5:16 PM EDT

Cyclerion Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Revenue
2.082-0.33.942.3
Upgrade
Revenue Growth (YoY)
----92.47%71.69%-49.06%
Upgrade
Cost of Revenue
---5.5837.6456.41
Upgrade
Gross Profit
2.082--5.28-33.69-54.12
Upgrade
Selling, General & Admin
5.275.348.3313.2620.6228.82
Upgrade
Research & Development
0.280.291.32---
Upgrade
Operating Expenses
5.555.639.6513.2620.6228.82
Upgrade
Operating Income
-3.47-3.63-9.65-18.54-54.31-82.93
Upgrade
Interest Expense
-----0.02-
Upgrade
Interest & Investment Income
0.160.210.360.29-0.3
Upgrade
Other Non Operating Income (Expenses)
0.360.36---0.29
Upgrade
EBT Excluding Unusual Items
-2.94-3.06-9.29-18.25-54.33-82.35
Upgrade
Asset Writedown
---3.3---
Upgrade
Other Unusual Items
----2.684.54
Upgrade
Pretax Income
-2.94-3.06-12.59-18.25-51.65-77.8
Upgrade
Earnings From Continuing Operations
-2.94-3.06-12.59-18.25-51.65-77.8
Upgrade
Earnings From Discontinued Operations
--7.33-25.83--
Upgrade
Net Income
-2.94-3.06-5.26-44.08-51.65-77.8
Upgrade
Net Income to Common
-2.94-3.06-5.26-44.08-51.65-77.8
Upgrade
Shares Outstanding (Basic)
332222
Upgrade
Shares Outstanding (Diluted)
332222
Upgrade
Shares Change (YoY)
4.80%7.70%7.59%11.03%28.75%11.04%
Upgrade
EPS (Basic)
-1.16-1.21-2.25-20.28-26.39-51.18
Upgrade
EPS (Diluted)
-1.16-1.21-2.25-20.28-26.39-51.18
Upgrade
Free Cash Flow
-3.43-4.33-21.25-40.61-36.52-74.01
Upgrade
Free Cash Flow Per Share
-1.35-1.72-9.09-18.69-18.66-48.69
Upgrade
Gross Margin
100.00%100.00%----
Upgrade
Operating Margin
-166.60%-181.40%--6242.42%-1377.83%-3612.11%
Upgrade
Profit Margin
-141.47%-152.85%--14841.08%-1310.17%-3388.59%
Upgrade
Free Cash Flow Margin
-164.82%-216.65%--13673.74%-926.53%-3223.61%
Upgrade
EBITDA
---9.58-18.48-53.84-80.64
Upgrade
D&A For EBITDA
--0.070.070.472.3
Upgrade
EBIT
-3.47-3.63-9.65-18.54-54.31-82.93
Upgrade
EBIT Margin
-166.60%-181.40%----
Upgrade
Revenue as Reported
2.082-0.33.942.3
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q